Repligen | RGEN - Ebitda

股票价格
117.60
每天变化
3.54 3.10%
每月一次
2.87%
每年
-18.76%
Q2 预测
115.08


金融业
股票价格
USD
资产
USD 2.95B
现金及等价物
USD 566.02M
销售成本
USD 94.08M
流动资产
USD 1.14B
流动负债
USD 135.83M
债务
USD 542.21M
EBIT
USD 19.97M
EBITDA
USD 39.54M
员工
1.78K
EPS每股收益
USD 0.49
股本和储备
USD 2.11B
销售毛利
USD 103.83M
债务利息支出
USD 5.5M
利息收入
USD 7.31M
贷款资金
USD 542.21M
市值
USD 6.36B
净收入
USD 13.29M
营业费用
USD 177.95M
营业利润
USD 19.97M
普通股股本
USD 56.33M
PE价格收益
164.06
税前利润
USD 17.11M
销售收入
USD 197.91M
销售和管理费用
USD 74.36M
股票
USD 170.46M
贸易债权人
USD 30.01M
应收帐款人
USD 158.59M


Ebitda 更改 日
Agilent USD 540M 74M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bio Techne USD 103.42M 7.47M 2025-12
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Bruker USD 211.6M 207.4M 2025-12
Charles River Laboratories USD 258.06M 24.83M 2025-12
Danaher USD 1.92B 204M 2026-03
Dentsply International USD 135M 32M 2025-12
General Electric Aerospace USD 2.84B 568M 2026-03
Henry Schein USD 291M 4M 2025-12
Illumina USD 332M 12M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
Mettler Toledo International USD 322.64M 26.75M 2025-09
Myriad Genetics USD 14.3M 4M 2025-12
OraSure Technologies USD -17.7M 4.06M 2025-12
Pacific Biosciences Of California USD -35.4M 5.78M 2025-09
Pfizer USD 6.08B 351M 2025-09
Repligen USD 39.54M 3.61M 2025-12
Revvity USD 248.91M 48.52M 2025-12
Standard Biotools USD -15.81M 734K 2025-12
Thermo Fisher Scientific USD 2.7B 464M 2026-03
Waters USD 380.97M 85.83M 2025-12
West Pharmaceutical Services USD 226.2M 7.7M 2026-03